The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Open accessAbstract
Both psychedelics and meditation exert profound modulatory effects on consciousness, perception and cognition, but their combined, possibly synergistic effects on neurobiology are unknown. Accordingly, we conducted a randomized, double-blind, placebo-controlled study with 38 participants following a single administration of the psychedelic psilocybin (315 μg/kg p.o.) during a 5-day mindfulness retreat. Brain dynamics were quantified directly pre- and post-intervention by functional magnetic resonance imaging during the resting state and two meditation forms. The analysis of functional connectivity identified psilocybin-related and mental state-dependent alterations in self-referential processing regions of the default mode network (DMN). Notably, decoupling of medial prefrontal and posterior cingulate cortices, which is thought to mediate sense of self, was associated with the subjective ego dissolution effect during the psilocybin-assisted mindfulness session. The extent of ego dissolution and brain connectivity predicted positive changes in psycho-social functioning of participants 4 months later. Psilocybin, combined with meditation, facilitated neurodynamic modulations in self-referential networks, subserving the process of meditation by acting along the anterior-posterior DMN connection. The study highlights the link between altered self-experience and subsequent behavioral changes. Understanding how interventions facilitate transformative experiences may open novel therapeutic perspectives. Insights into the biology of discrete mental states foster our understanding of non-ordinary forms of human self-consciousness and their concomitant brain substrate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During these processes, rigid thought patterns are loosened and experiences of ego-dissolution and deep universal connections are reported. 54”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [54]
In the citing paper
“Smigielski and colleagues [7, 108] reported similar outcomes following the administration of psilocybin to individuals with long-term experience of mindfulness meditation during a 5-day Zen meditation retreat.”
From Mindfulness meditation and psychedelics: potential synergies and commonalities (2023) · cites this paper as [108]
In the citing paper
“This was a double-blind, placebo-controlled trial involving 38 participants who were screened with psychometric instruments and in addition with functional magnetic resonance imaging during the resting state and two meditation forms, pre to post-intervention.”
From Mindfulness meditation and psychedelics: potential synergies and commonalities (2023) · cites this paper as [108]
In the citing paper
“Furthermore, when psilocybin was administered to long-term mindfulness meditators, it led to enhanced context-dependent DMN flexibility, as the meditators who had received psilocybin were able to downregulate DMN activity significantly more than the comparison group, during mindfulness meditation (101).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [101]
Citations
Cites
1 retracted
Gotink, R. A., Chu, P., Busschbach, J. J. V., Benson, H., Fricchione, G. L., & Hunink, M. G. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124344 · Cited by 539
RetractedTzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
An Information-Maximization Approach to Blind Separation and Blind Deconvolution
Bell, A. J., & Sejnowski, T. J. (1995) · Neural Computation · doi:10.1162/neco.1995.7.6.1129 · Cited by 8,986
Mindfulness: A proposed operational definition.
Bishop, S. R., Lau, M., Shapiro, S., Carlson, L., Anderson, N. D., Carmody, J., Segal, Z. V., Abbey, S., Speca, M., Velting, D., et al. (2004) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bph077 · Cited by 7,234
Cognitive and emotional influences in anterior cingulate cortex
Bush, G., Luu, P., & Posner, M. I. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01483-2 · Cited by 6,259
The precuneus: a review of its functional anatomy and behavioural correlates
Cavanna, A. E., & Trimble, M. R. (2006) · Brain · doi:10.1093/brain/awl004 · Cited by 5,128
A component based noise correction method (CompCor) for BOLD and perfusion based fMRI
Behzadi, Y., Restom, K., Liau, J., & Liu, T. T. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.04.042 · Cited by 4,502
The brain's default mode network
Raichle, M. E. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014030 · Cited by 3,904
Investigations into resting-state connectivity using independent component analysis
Beckmann, C. F., DeLuca, M., Devlin, J. T., & Smith, S. M. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1634 · Cited by 3,398
A method for making group inferences from functional MRI data using independent component analysis
Calhoun, V. D., Adali, T., Pearlson, G. D., & Pekar, J. J. (2001) · Human Brain Mapping · doi:10.1002/hbm.1048 · Cited by 2,994
Research works printed but not linked: 1
- Schreckenberger, 1998, The psilocybin psychosis as a model psychosis paradigma for acute schizophrenia: a PET study with 18-FDG, Eur. J. Nucl. Med., 25, 877
Cited by
Sorted by citations
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570
Self-citationEmotions and brain function are altered up to one month after a single high dose of psilocybin.
Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-59282-y · Cited by 375
Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., Hutten, N. R. P. W., Jansen, J. F. A., Stiers, P., Feilding, A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0718-8 · Cited by 258
Long-term effects of psychedelic drugs: A systematic review
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.017 · Cited by 279
Default Mode Network Modulation by Psychedelics: A Systematic Review
Gattuso, J. J., Perkins, D., Ruffell, S., Lawrence, A. J., Hoyer, D., Jacobson, L. H., Timmermann, C., Castle, D., Rossell, S. L., Downey, L. A., et al. (2023) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac074 · Cited by 256
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
van Elk, M., & Yaden, D. B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104793 · Cited by 221
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Burback, L., Brémault‐Phillips, S., Nijdam, M. J., McFARLANE, A. C., & Vermetten, E. H. G. J. M. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230428091433 · Cited by 251
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Wolff, M., Evens, R., Mertens, L. J., Koslowski, M., Betzler, F., Gründer, G., & Jungaberle, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00005 · Cited by 205
Barrett, F. S., Krimmel, S. R., Griffiths, R. R., Seminowicz, D. A., & Mathur, B. N. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116980 · Cited by 199
Timmermann, C., Bauer, P. R., Gosseries, O., Vanhaudenhuyse, A., Vollenweider, F., Laureys, S., Singer, T., Antonova, E., & Lutz, A. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2022.11.006 · Cited by 150
Self-citationBrouwer, A., & Carhart-Harris, R. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120959637 · Cited by 174
Safron, A. (2020) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2020.00030 · Cited by 133
Spontaneous and deliberate creative cognition during and after psilocybin exposure
Mason, N. L., Kuypers, K. P. C., Reckweg, J. T., Müller, F., Tse, D. H. Y., Rios, B. D., Toennes, S. W., Stiers, P. L. J., Feilding, A., & Ramaekers, J. G. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01335-5 · Cited by 144
Meditation Increases the Entropy of Brain Oscillatory Activity
Vivot, R. M., Pallavicini, C., Zamberlán, F., Vigo, D. E., & Tagliazucchi, E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.01.033 · Cited by 116
Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis
Roméo, B., Karila, L., Martelli, C., & Benyamina, A. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120919957 · Cited by 122
Classic Psychedelic Drugs: Update on Biological Mechanisms
Vollenweider, F. X., & Smallridge, J. W. (2022) · Pharmacopsychiatry · doi:10.1055/a-1721-2914 · Cited by 119
Self-citationMcCulloch, D. E.-W., Knudsen, G. M., Barrett, F. S., Doss, M. K., Carhart-Harris, R. L., Rosas, F. E., Deco, G., Kringelbach, M. L., Preller, K. H., Ramaekers, J. G., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104689 · Cited by 110
Dose–response relationships of psilocybin-induced subjective experiences in humans
Hirschfeld, T., & Schmidt, T. T. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121992676 · Cited by 97
Heuschkel, K., & Kuypers, K. P. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00224 · Cited by 86
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Stoliker, D., Egan, G. F., Friston, K. J., & Razi, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000508 · Cited by 96
McCulloch, D. E.-W., Madsen, M. K., Stenbæk, D. S., Kristiansen, S., Ozenne, B., Jensen, P. S., Knudsen, G. M., & Fisher, P. M. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211026454 · Cited by 83
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice
Payne, J. E., Chambers, R., & Liknaitzky, P. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00034 · Cited by 78
Decreased directed functional connectivity in the psychedelic state
Barnett, L., Muthukumaraswamy, S. D., Carhart-Harris, R. L., & Seth, A. K. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116462 · Cited by 83
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 92
Romeo, B., Hermand, M., Pétillion, A., Karila, L., & Benyamina, A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.03.002 · Cited by 76
Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review
Divito, A. J., & Leger, R. F. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-06009-x · Cited by 78
Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69
Raut, S. B., Marathe, P. A., van Eijk, L., Eri, R. D., Ravindran, M., Benedek, D. M., Ursano, R. J., Canales, J. J., & Johnson, L. R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108195 · Cited by 74
Content-free awareness: EEG-fcMRI correlates of consciousness as such in an expert meditator
Winter, U., LeVan, P., Borghardt, T. L., Akin, B., Wittmann, M., Leyens, Y., & Schmidt, S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.03064 · Cited by 63
Zeifman, R. J., & Wagner, A. C. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.001 · Cited by 67
Giluk (2009) · doi:10.1017/s003329172000389x · Cited by 68
A unified model of ketamine’s dissociative and psychedelic properties
Marguilho, M., Figueiredo, I., & Castro-Rodrigues, P. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221140011 · Cited by 71
Gandy, S., Forstmann, M., Carhart-Harris, R. L., Timmermann, C., Luke, D. P., & Watts, R. (2020) · Health Psychology Open · doi:10.1177/2055102920978123 · Cited by 70
Psychedelics as a Treatment for Alzheimer’s Disease Dementia
Jones, S. V., & O’Kelly, A. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00034 · Cited by 68
dos Santos, R. G., Hallak, J. E., Baker, G., & Dursun, S. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120986422 · Cited by 55
Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments
Richardson, B., MacPherson, A., & Bambico, F. R. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100554 · Cited by 57
On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS)
Safron, A., Juliani, A., Reggente, N., Klimaj, V., & Johnson, M. W. (2025) · Neuroscience of Consciousness · doi:10.1093/nc/niae038 · Cited by 57
Safron, A. (2021) · Entropy · doi:10.3390/e23060783 · Cited by 59
Husain, M. I., Ledwos, N., Fellows, E., Baer, J., Rosenblat, J. D., Blumberger, D. M., Mulsant, B. H., & Castle, D. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1076459 · Cited by 50
Zamboni, L., Centoni, F., Fusina, F., Mantovani, E., Rubino, F., Lugoboni, F., & Federico, A. (2021) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001381 · Cited by 54
Psychedelics and potential benefits in “healthy normals”: A review of the literature
Gandy, S. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.029 · Cited by 52
Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences
Kähönen, J. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1104627 · Cited by 50
Hayes, S. C., Law, S., Malady, M., Zhu, Z., & Bai, X. (2019) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.005 · Cited by 49
Mindfulness meditation and psychedelics: potential synergies and commonalities
Holas, P., & Kamińska, J. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00551-8 · Cited by 43
“Smigielski and colleagues [7, 108] reported similar outcomes following the administration of psilocybin to individuals with long-term experience of mindfulness meditation during a 5-day Zen meditation retreat.”
BackgroundYu, Z., Burback, L., Winkler, O., Xu, L., Dennett, L., Vermetten, E. H. G. J. M., Greenshaw, A. J., Li, X., Milne, M., Wang, F., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1386321 · Cited by 49
Targeting the 5-HT system: Potential side effects
Hoyer, D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108233 · Cited by 43
Eleftheriou, M. E., & Thomas, E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.707057 · Cited by 39
Orłowski, P., Ruban, A., Szczypiński, J., Hobot, J., Bielecki, M., & Bola, M. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221089034 · Cited by 41
Smigielski, L., Kometer, M., Scheidegger, M., Stress, C., Preller, K. H., Koenig, T. W., & Vollenweider, F. X. (2020) · Human Brain Mapping · doi:10.1002/hbm.25174 · Cited by 43
Self-citationDefault mode network activity in depression subtypes
Borserio, B. J., Sharpley, C. F., Bitsika, V., Sarmukadam, K., Fourie, P. J., & Agnew, L. L. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0132 · Cited by 41
Koslowski, M., Johnson, M. W., Gründer, G., & Betzler, F. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00401-8 · Cited by 42
Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans
Moujaes, F., Preller, K. H., Ji, J. L., Murray, J. D., Berkovitch, L., Vollenweider, F. X., & Anticevic, A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.10.021 · Cited by 38
Self-citationAbellaneda‐Pérez, K., Potash, R. M., Pascual‐Leone, Á., & Sacchet, M. D. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105862 · Cited by 49
Resting-state functional MRI of the default mode network in epilepsy
Gonen, O. M., Kwan, P., O'Brien, T. J., LUI, E. H., & Desmond, P. M. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107308 · Cited by 44
Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy
Thal, S. B., Bright, S. J., Sharbanee, J. M., Wenge, T., & Skeffington, P. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.617224 · Cited by 38
Psiuk, D., Nowak, E., Dycha, N., Łopuszańska, U., Kurzepa, J., & Samardakiewicz, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911450 · Cited by 46
Zoubi, O. A., Misaki, M., Bodurka, J., Kuplicki, R., Wohlrab, C., Schoenhals, W. A., Refai, H. H., Khalsa, S. S., Stein, M. B., Paulus, M. P., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25429 · Cited by 41
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Allen, J., Dames, S., Foldi, C. J., & Shultz, S. R. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02360-0 · Cited by 40
Safron, A., & DeYoung, C. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819200-9.00010-7 · Cited by 34
Gaddis, A., Lidstone, D. E., Nebel, M. B., Griffiths, R. R., Mostofsky, S. H., Mejia, A. F., & Barrett, F. S. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119434 · Cited by 46
Toward staging differentiation for posttraumatic stress disorder treatment
Nijdam, M. J., Vermetten, E. H. G. J. M., & McFARLANE, A. C. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13520 · Cited by 39
Nootropic effects of LSD: Behavioral, molecular and computational evidence
Ornelas, I. M., da Silva, F. A. C., Wießner, I., Marcos, E., de Araújo, D. B., Goto‐Silva, L., Nascimento, J. M., Silva, S. R. B., Costa, M., Falchi-Carvalho, M., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114148 · Cited by 37
Dourron, H. M., Strauss, C. K., & Hendricks, P. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000514 · Cited by 35
Braun, D., Rosenberg, A. M., Rabaniam, E., Haruvi, R., Malamud, D., Barbara, R., Aiznkot, T., Levavi‐Sivan, B., & Kawashima, T. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02391-7 · Cited by 42
Søndergaard, A., Madsen, M. K., Ozenne, B., Armand, S., Knudsen, G. M., Fisher, P. M., & Stenbæk, D. S. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.948729 · Cited by 37
Pagni, B. A., Petridis, P. D., Podrebarac, S. K., Grinband, J., Claus, E. D., & Bogenschutz, M. P. (2024) · Scientific Reports · doi:10.1038/s41598-024-52967-8 · Cited by 37
Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report
Kelmendi, B., Kichuk, S. A., DePalmer, G., Maloney, G. K., Ching, T. H. W., Belser, A., & Pittenger, C. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12135 · Cited by 44
Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms
Garcia‐Romeu, A., Darcy, S., Jackson, H., White, T., & Rosenberg, P. B. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_267 · Cited by 33
Long-term maintenance of multitasking abilities following video game training in older adults
Anguera, J. A., Schachtner, J. N., Simon, A. J., Volponi, J. J., Javed, S., Gallen, C. L., & Gazzaley, A. H. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.02.023 · Cited by 30
The Altered States Database: Psychometric data from a systematic literature review
Prugger, J., Derdiyok, E., Dinkelacker, J., Costines, C., & Schmidt, T. T. (2022) · Scientific Data · doi:10.1038/s41597-022-01822-4 · Cited by 36
Parvizi-Wayne, D., Sandved-Smith, L., Pitliya, R. J., Limanowski, J., Tufft, M. R. A., & Friston, K. J. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1354719 · Cited by 37
Neural mechanisms of psychedelic visual imagery
Stoliker, D., Preller, K. H., Novelli, L., Anticevic, A., Egan, G. F., Vollenweider, F. X., & Razi, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02632-3 · Cited by 36
Self-citationChing, T. H. W., Grazioplene, R., Bohner, C., Kichuk, S. A., DePalmer, G., D’Amico, E., Eilbott, J., Jankovsky, A., Burke, M., Hokanson, J., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1178529 · Cited by 29
Pharmacokinetics of Psilocybin: A Systematic Review
Meshkat, S., Al-Shamali, H. F., Perivolaris, A., Tullu, T., Zeifman, R. J., Zhang, Y., Burback, L., Winkler, O., Greenshaw, A. J., Husain, M. I., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040411 · Cited by 34
Beating pain with psychedelics: Matter over mind?
Elman, I., Pustilnik, A. C., & Borsook, D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.005 · Cited by 30
Lyubomirsky, S. (2022) · Perspectives on Psychological Science · doi:10.1177/17456916211055369 · Cited by 34
Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation
Modlin, N. L., Miller, T. M., Rucker, J., Kirlić, N., Lennard-Jones, M., Schlosser, D. A., & Aaronson, S. T. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.077 · Cited by 31
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Banushi, B., & Polito, V. (2023) · Biology · doi:10.3390/biology12111380 · Cited by 33
Animal Behavior in Psychedelic Research
Odland, A. U., Kristensen, J. L., & Andreasen, J. T. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000590 · Cited by 30
Psilocybin for the treatment of Alzheimer’s disease
Zheng, S., Ma, R., Yang, Y., & Li, G. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1420601 · Cited by 27
Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy
Sekula, A. D., Downey, L. A., & Puspanathan, P. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.813746 · Cited by 30
Mortaheb, S., Fort, L. D., Mason, N. L., Mallaroni, P., Ramaekers, J. G., & Athena Demertzi, A. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.04.001 · Cited by 31
Felsch, C. L., & Kuypers, K. P. C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104724 · Cited by 25
Psychedelic medicines for mood disorders: current evidence and clinical considerations.
Sarris, J. J., Rubiano, D. P., Day, K., Coelho, N. L. G., & Perkins, D. (2022) · PubMed · doi:10.1097/yco.0000000000000759 · Cited by 12
Thal, S. B., Wieberneit, M., Sharbanee, J. M., Skeffington, P., Baker, P., Bruno, R., Wenge, T., & Bright, S. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221127954 · Cited by 24
Beaussant, Y., Tarbi, E., Nigam, K., Miner, S., Sager, Z., Sanders, J. J., Ljuslin, M., Guérin, B., Thambi, P., Tulsky, J. A., et al. (2024) · Cancer · doi:10.1002/cncr.35024 · Cited by 25
Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review
Watford, T., & Masood, N. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1120 · Cited by 23
Averill, L. A., & Abdallah, C. G. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2035358 · Cited by 23
Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome
Buzzelli, V., Carbone, E., Manduca, A., Schiavi, S., Feo, A., Perederiy, J. V., Ambert, K. H., Hausman, M., & Trezza, V. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06286-3 · Cited by 22
Tolle, H. M., Farah, J. C., Mallaroni, P., Mason, N. L., Ramaekers, J. G., & Amico, E. (2023) · Network Neuroscience · doi:10.1162/netn_a_00349 · Cited by 21
Shinozuka, K., Jerotic, K., Mediano, P. A. M., Zhao, A. T., Preller, K. H., Carhart-Harris, R. L., & Kringelbach, M. L. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03187-1 · Cited by 28
Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?
Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2019) · Journal of Cognitive Enhancement · doi:10.1007/s41465-019-00151-6 · Cited by 23
Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective
Meling, D., & Scheidegger, M. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1100058 · Cited by 22
Self-citationComparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation
Moujaes, F., Rieser, N. M., Phillips, C. L. M., de Matos, N. M. P., Brügger, M., Duerler, P., Smigielski, L., Stämpfli, P., Seifritz, E., Vollenweider, F. X., et al. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.07.003 · Cited by 25
Self-citationGermann, C. B. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109406 · Cited by 20
Default mode network functional connectivity negatively associated with trait openness to experience
Marstrand-Joergensen, M. R., Madsen, M. K., Stenbæk, D. S., Ozenne, B., Jensen, P. S., Frøkjær, V. G., Knudsen, G. M., & Fisher, P. M. (2021) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsab048 · Cited by 22
Validation of the imperial psychedelic predictor scale
Angyus, M., Osborn, S., Haijen, E. C. H. M., Erritzøe, D., Peill, J. M., Lyons, T., Kettner, H., & Carhart-Harris, R. L. (2024) · Psychological Medicine · doi:10.1017/s0033291724002204 · Cited by 20
Inserra, A., Piot, A., Gregorio, D. D., & Gobbi, G. (2023) · CNS Drugs · doi:10.1007/s40263-023-01008-5 · Cited by 19
Psychedelics and disorders of consciousness: the current landscape and the path forward
Cardone, P., Alnagger, N., Annen, J., Bicego, A., Gosseries, O., & Martial, C. (2024) · Neuroscience of Consciousness · doi:10.1093/nc/niae025 · Cited by 18
Metadata
- Authors
- Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Smigielski, Lukasz
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 196
- Pages
- 207-215
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2926998013
- Cited by
- 248
- References
- 83
- Citations by year
- 2026: 20 · 2025: 43 · 2024: 45 · 2023: 29 · 2022: 45 · 2021: 31 · 2020: 26 · 2019: 8
- FWCI
- 32.13
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- NeuroImage (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Swiss Neuromatrix Foundation (2014-0101)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Keywords
- psilocybin, mindfulness meditation, self-consciousness, default mode network, functional connectivity, ego dissolution, medial prefrontal cortex, posterior cingulate cortex, self-referential processing, psychedelics, meditation, long-term mental health outcomes, altered states of consciousness
- MeSH terms
- Brain, Brain Mapping, Consciousness, Double-Blind Method, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neural Pathways, Psilocybin, Self Concept, Meditation, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review